"It's hard for us men to go to the clinic. We naturally have a fear of hospitals." Men's risk perceptions, experiences and program preferences for PrEP: A mixed methods study in Eswatini

被引:14
作者
Berner-Rodoreda, Astrid [1 ]
Geldsetzer, Pascal [1 ,2 ]
Baernighausen, Kate [1 ,3 ]
Hettema, Anita [4 ,8 ]
Baernighausen, Till [1 ,5 ]
Matse, Sindy [6 ]
McMahon, Shannon A. [1 ,7 ]
机构
[1] Ruprecht Karls Univ Heidelberg, Inst Global Hlth, Heidelberg, Germany
[2] Stanford Univ, Dept Med, Div Primary Care & Populat Hlth, Stanford, CA 94305 USA
[3] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa
[4] Clinton Hlth Access Initiat Swaziland, Mbabane, Eswatini
[5] Harvard TH Chan Sch Publ Hlth, Boston, MA USA
[6] Eswatini Minist Hlth, Mbabane, Eswatini
[7] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA
[8] Clinton Hlth Access Initiat, Corner Mbilibhi & Tsekwane St, Mbabane, Eswatini
来源
PLOS ONE | 2020年 / 15卷 / 09期
基金
美国国家卫生研究院;
关键词
PREEXPOSURE PROPHYLAXIS PREP; HIV PREVENTION; ANTIRETROVIRAL THERAPY; HETEROSEXUAL MEN; SEXUAL-BEHAVIOR; SOUTH-AFRICA; COMPENSATION; PARTICIPANTS; STRATEGIES; ADHERENCE;
D O I
10.1371/journal.pone.0237427
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Few studies on HIV Pre-Exposure Prophylaxis (PrEP) have focused on men who have sex with women. We present findings from a mixed-methods study in Eswatini, the country with the highest HIV prevalence in the world (27%). Our findings are based on risk assessments, in-depth interviews and focus-group discussions which describe men's motivations for taking up or declining PrEP. Quantitatively, men self-reported starting PrEP because they had multiple or sero-discordant partners or did not know the partner's HIV-status. Men's self-perception of risk was echoed in the qualitative data, which revealed that the hope of facilitated sexual performance or relations, a preference for pills over condoms and the desire to protect themselves and others also played a role for men to initiate PrEP. Trust and mistrust and being able or unable to speak about PrEP with partner(s) were further considerations for initiating or declining PrEP. Once on PrEP, men's sexual behavior varied in terms of number of partners and condom use. Men viewed daily pill-taking as an obstacle to starting PrEP. Side-effects were a major reason for men to discontinue PrEP. Men also worried that taking anti-retroviral drugs daily might leave them mistaken for a person living with HIV, and viewed clinic-based PrEP education and initiation processes as a further obstacle. Given that men comprise only 29% of all PrEP users in Eswatini, barriers to men's uptake of PrEP will need to be addressed, in terms of more male-friendly services as well as trialing community-based PrEP education and service delivery.
引用
收藏
页数:20
相关论文
共 75 条
  • [1] Potential Impact of Antiretroviral Chemoprophylaxis on HIV-1 Transmission in Resource-Limited Settings
    Abbas, Ume L.
    Anderson, Roy M.
    Mellors, John W.
    [J]. PLOS ONE, 2007, 2 (09):
  • [2] [Anonymous], 2010, SLUZBENI GLASNIK RS
  • [3] Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study
    Atujuna, Millicent
    Newman, Peter A.
    Wallace, Melissa
    Eluhu, Megan
    Rubincam, Clara
    Brown, Ben
    Bekker, Linda-Gail
    [J]. PLOS ONE, 2018, 13 (02):
  • [4] "We know this will be hard at the beginning, but better in the long term": understanding PrEP uptake in the general population in Eswatini
    Baernighausen, Kate
    Matse, Sindy
    Hughey, Allison B.
    Hettema, Anita
    Baernighausen, Till W.
    McMahon, Shannon A.
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2020, 32 (02): : 267 - 273
  • [5] Bärnighausen KE, 2019, AIDS, V33, pS45, DOI [10.1097/qad.0000000000002178, 10.1097/QAD.0000000000002178]
  • [6] Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
    Baeten, J. M.
    Donnell, D.
    Ndase, P.
    Mugo, N. R.
    Campbell, J. D.
    Wangisi, J.
    Tappero, J. W.
    Bukusi, E. A.
    Cohen, C. R.
    Katabira, E.
    Ronald, A.
    Tumwesigye, E.
    Were, E.
    Fife, K. H.
    Kiarie, J.
    Farquhar, C.
    John-Stewart, G.
    Kakia, A.
    Odoyo, J.
    Mucunguzi, A.
    Nakku-Joloba, E.
    Twesigye, R.
    Ngure, K.
    Apaka, C.
    Tamooh, H.
    Gabona, F.
    Mujugira, A.
    Panteleeff, D.
    Thomas, K. K.
    Kidoguchi, L.
    Krows, M.
    Revall, J.
    Morrison, S.
    Haugen, H.
    Emmanuel-Ogier, M.
    Ondrejcek, L.
    Coombs, R. W.
    Frenkel, L.
    Hendrix, C.
    Bumpus, N. N.
    Bangsberg, D.
    Haberer, J. E.
    Stevens, W. S.
    Lingappa, J. R.
    Celum, C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (05) : 399 - 410
  • [7] Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda
    Baeten, Jared M.
    Heffron, Renee
    Kidoguchi, Lara
    Mugo, Nelly R.
    Katabira, Elly
    Bukusi, Elizabeth A.
    Asiimwe, Stephen
    Haberer, Jessica E.
    Morton, Jennifer
    Ngure, Kenneth
    Bulya, Nulu
    Odoyo, Josephine
    Tindimwebwa, Edna
    Hendrix, Craig
    Marzinke, Mark A.
    Ware, Norma C.
    Wyatt, Monique A.
    Morrison, Susan
    Haugen, Harald
    Mujugira, Andrew
    Donnell, Deborah
    Celum, Connie
    [J]. PLOS MEDICINE, 2016, 13 (08)
  • [8] Men's health: a global problem requiring global solutions
    Baker, Peter
    [J]. TRENDS IN UROLOGY & MENS HEALTH, 2016, 7 (03) : 11 - 14
  • [9] Berner-Rodoreda A, 2018, INTEREST C KIG RWAND
  • [10] Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa
    Bor, Jacob
    Fox, Matthew P.
    Rosen, Sydney
    Venkataramani, Atheendar
    Tanser, Frank
    Pillay, Deenan
    Baernighausen, Till
    [J]. PLOS MEDICINE, 2017, 14 (11)